• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pain management in gout.

作者信息

Kirby Brian S, McTigue Joan C, Edwards N Lawrence

出版信息

Curr Pain Headache Rep. 2008 Dec;12(6):418-22. doi: 10.1007/s11916-008-0071-9.

DOI:10.1007/s11916-008-0071-9
PMID:18973734
Abstract

Gout is currently the most common form of inflammatory arthritis in men. The overall incidence of gout has increased rapidly in the past 20 years. Clinicians in all fields are likely to experience a patient with acute gout in their career. Uncontrolled gout and hyperuricemia can lead to joint destruction and significant morbidity. Fortunately, these diseases can be readily treated and long-term sequelae can be prevented. Recent advances in understanding the role of the innate immune system in acute gout have provided new treatment options. This article addresses the epidemiology, inflammatory pathophysiology, pain management techniques (including recent advances), and treatment of the underlying disease itself.

摘要

相似文献

1
Pain management in gout.
Curr Pain Headache Rep. 2008 Dec;12(6):418-22. doi: 10.1007/s11916-008-0071-9.
2
Recognition and management of gout and hyperuricemia.痛风与高尿酸血症的识别与管理
JAAPA. 2003 Mar;16(3):21-4, 27-8, 31.
3
Management of gout: a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency.痛风的治疗:一位 57 岁男性,有痛风石病史、高尿酸血症和轻度肾功能不全。
JAMA. 2012 Nov 28;308(20):2133-41. doi: 10.1001/jama.2012.65028.
4
Current and future therapeutic options for the management of gout.痛风管理的当前和未来治疗选择。
Am J Ther. 2010 Jul-Aug;17(4):402-17. doi: 10.1097/MJT.0b013e3181df8ad2.
5
Gout and hyperuricemia: diagnosis and management.痛风与高尿酸血症:诊断与管理
Hosp Pract (Off Ed). 1986 Nov 15;21(11):119-26, 131-2.
6
Hyperuricemia and gout: a reign of complacency.高尿酸血症与痛风:一片自满的领域
Cleve Clin J Med. 2002 Aug;69(8):589-90, 592-3. doi: 10.3949/ccjm.69.8.589.
7
Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial.首次医疗接触时即开始使用别嘌醇治疗急性痛风发作:一项随机临床试验。
Am J Med. 2012 Nov;125(11):1126-1134.e7. doi: 10.1016/j.amjmed.2012.05.025.
8
Updates in the management of gout.痛风管理的最新进展。
Am J Med. 2007 Mar;120(3):221-4. doi: 10.1016/j.amjmed.2006.02.044.
9
Managing your patient with gout: a review of treatment options.管理痛风患者:治疗选择综述。
Postgrad Med. 2011 May;123(3):56-71. doi: 10.3810/pgm.2011.05.2284.
10
Management of gout.
Ann Intern Med. 1979 May;90(5):812-6. doi: 10.7326/0003-4819-90-5-812.

引用本文的文献

1
Generalized pain hypersensitivity and associated factors in gout.痛风的广义疼痛敏感性及其相关因素。
Rheumatology (Oxford). 2022 Aug 30;61(9):3640-3646. doi: 10.1093/rheumatology/keab934.

本文引用的文献

1
Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study.肾功能损害患者慢性痛风的治疗:一项开放、随机、积极对照研究。
J Clin Rheumatol. 1999 Apr;5(2):49-55. doi: 10.1097/00124743-199904000-00003.
2
Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.软饮料、果糖摄入与男性痛风风险:前瞻性队列研究
BMJ. 2008 Feb 9;336(7639):309-12. doi: 10.1136/bmj.39449.819271.BE. Epub 2008 Jan 31.
3
Ultrasonographic measurement of tophi as an outcome measure for chronic gout.
超声测量痛风石作为慢性痛风的一项疗效指标。
J Rheumatol. 2007 Sep;34(9):1888-93. Epub 2007 Jul 15.
4
Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout.基线疾病及患者特征与依托考昔和吲哚美辛治疗急性痛风疗效的相关性
Curr Med Res Opin. 2007 Jul;23(7):1685-91. doi: 10.1185/030079907x210750.
5
Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout.每日一次服用400毫克氯美昔布治疗痛风急性发作,疗效与每日三次服用50毫克吲哚美辛相当。
Rheumatology (Oxford). 2007 Jul;46(7):1126-32. doi: 10.1093/rheumatology/kem090. Epub 2007 May 3.
6
Prevalence of the metabolic syndrome in individuals with hyperuricemia.高尿酸血症患者中代谢综合征的患病率。
Am J Med. 2007 May;120(5):442-7. doi: 10.1016/j.amjmed.2006.06.040.
7
A pilot study of IL-1 inhibition by anakinra in acute gout.阿那白滞素对急性痛风中白细胞介素-1抑制作用的一项初步研究。
Arthritis Res Ther. 2007;9(2):R28. doi: 10.1186/ar2143.
8
Anakinra for the treatment of neonatal-onset multisystem inflammatory disease.阿那白滞素用于治疗新生儿期多系统炎症性疾病。
Nat Clin Pract Rheumatol. 2006 Dec;2(12):646-7. doi: 10.1038/ncprheum0350.
9
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).欧洲抗风湿病联盟关于痛风的循证推荐意见。第二部分:管理。欧洲抗风湿病联盟国际临床研究包括治疗学常务委员会(ESCISIT)特别工作组报告
Ann Rheum Dis. 2006 Oct;65(10):1312-24. doi: 10.1136/ard.2006.055269. Epub 2006 May 17.
10
Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.由Toll样受体2和4以及髓样分化因子88表达赋予的先天免疫对于尿酸单钠一水合物晶体诱导的炎症至关重要。
Arthritis Rheum. 2005 Sep;52(9):2936-46. doi: 10.1002/art.21238.